We studied how lowering a syringe pump and changing the out¯ow pressure could affect syringe pump output. We experimentally reduced the height of three different syringe pump systems by 80 cm (adult setting) or 130 cm (neonatal setting), as can happen clinically, using ®ve¯ow rates. We measured the time of backward¯ow, no¯ow and the total time without
Variation in¯ow rate affects nitroprusside pharmacodynamics in adults and children receiving continuous nitroprusside infusions. 3 Moving patients after surgery to the intensive care unit can destabilize them if they are being treated with catecholamines. 4 Lifting an infusion pump containing epinephrine by 80±100 cm while moving a patient from the operating table into bed after surgery led to critical increases in heart rate, blood pressure and left atrial pressure. 5 Experimentally, raising or lowering a syringe pump by 100 cm caused bolus administration or a critical delay in infusion, depending on the infusion rate. We found similar effects especially in newborns after correction of congenital heart disease. Lowering the syringe pump by a maximum of 80 cm in adults and by 130 cm in neonates could occur when preparing patients for transport from the theatre to the intensive care unit (Fig. 1) . We set out to measure (i) the delay of different syringe pumps after lowering the height of the pump by the maximum distance found in clinical practice; (ii) the effect of infusion rate on the output of the syringe pump when the out¯ow pressure was altered by lowering the syringe pump; (iii) the minimum infusion rate for each syringe pump system that gave a predetermined delay of infusion.
Materials and methods
The infusion volume during the change in out¯ow pressure and the time without ef®cient infusion for the patient were measured in a closed system using glass capillaries of 0.5 mm diameter and a total length of 1 m. At the end of the capillaries, a manometer was used to simulate a central venous pressure of 8 mm Hg (Fig. 2) .
One hour before changing out¯ow pressure, syringes were connected with the closed system and pumps were started with a minimum¯ow rate of 1 ml h ±1 . They were kept running throughout the experiment. When a coloured uid reached a marked area of the capillaries, the syringes were lowered by 80 or 130 cm for adult and neonatal settings respectively, and the time until the marked area was reached again was measured. The following values were determined: (i) the time of the re¯ux back into the infusion system of the liquid column; (ii) the distance of the re¯ux of the liquid column; (iii) the time without movement of the liquid column; and (iv) the time for the liquid column to reach the starting position again.
The infusion volume that was not administered was calculated according to the stopped time and¯ow rate (Fig. 3 ). This experiment was done using¯ow rates of 1, 2, 3, 5 and 10 ml h ±1 and repeating each measurement eight to 10 times. Afterwards, the syringes and the infusion systems were connected to a commercially available transducer (Ohmeda, Murray Hill, NJ, USA) and a patient monitor (Solar 8000; Marquette Medical Systems, Milwaukee, WI, USA) to determine the compliance of the different systems. The pressure increase from 0 to 300 mm Hg was timed at 25 mmHg intervals and the compliance of the different systems was calculated according to c=Dv/Dp using twō ow rates.
Materials
Three syringe pumps with their infusion systems were tested: (i) Injectomat-C (Frisenius, Oberursel, Germany) with a 150 cm infusion system (9000911); (ii) Ivac 770 (Ivac, San Diego, CA, USA) with a 200 cm infusion system (G30402); and (iii) Perfusor fm (B. Braun Melsungen Medical, Melsungen, Germany) with a 150 cm infusion system (N872 296/0).
A 50 ml Injectomat syringe was used for all experiments. The tested syringe pumps were used in clinical routine and were therefore checked regularly according to German law (Medizinproduktegesetz).
Statistical analysis
Results are given as mean (standard deviation) after normal distribution had been con®rmed with the Kolmogorov± Smirnov test. The exponential correlation between pairs of variables was tested by r 2 and linear correlation was determined with the Pearson correlation coef®cient. An exponential regression model was tested and the¯ow rate for a predetermined time without infusion was calculated for each system. The level of signi®cance was P<0.05. We used the software package SPSS 8.0 (SPSS, Chicago, IL, USA).
Results
Changing the out¯ow pressure by lowering the syringe pump by 80 and 130 cm reduced the delivered infusion by between 633 and 23 s depending on the¯ow (Table 1) . There was a statistically signi®cant (P<0.01), exponentially negative correlation between¯ow rate and time without effective infusion for all three systems tested. Using this exponential regression, we estimated the¯ow rates when there would be an effective time without infusion of 60 and 120 s (Table 2) . These rates were a minimum of 4.4 ml h ±1 for 60 s without infusion and a minimum of 2.6 ml h ±1 for 120 s without infusion for the adult setting. Lowering the syringe pump by 130 cm (neonatal setting), a minimum infusion rate of 6.0 ml h ±1 gave a time of 60 s and 4.3 ml h ±1 gave a time of 120 s without infusion. Testing the compliance of the different systems resulted in similar values for the Injectomat-C and the Perfusor fm (81 and 85 ml mm Hg ±1 respectively). The compliance of the Ivac 770 system was greater, at 103 ml mm Hg ±1 . There was a statistically signi®cant positive correlation (r 2 =0.863, P<0.05) between time without infusion and the compliance of the system. 
Discussion
We found that moving syringe pumps downwards, as we have been doing during transport after cardiac surgery, reduced the¯ow from the syringe pumps. The time without infusion was related to the infusion rate. Differences between the systems tested were probably caused by the different compliances of the connected infusion systems, and were correlated linearly with the observed time without infusion. The data presented do not endorse any particular manufacturer or model as an infusion device. Variation in¯ow rate from syringe pumps has been shown in experimental and clinical settings. 2 3 6 Differences in relative syringe pump height during transport are frequent during paediatric cardiac surgery. When transport incubators are used the syringe pumps may be lowered suddenly. Changes in¯ow of vasoactive drugs may contribute to the haemodynamic instability often seen when moving intensive care patients. 7 Relevant time without infusion was found up to infusion rates of >5 ml h ±1 . The greater compliance of the Ivac 770 system in¯uenced the marked effect of changes in out¯ow pressure on this apparatus. The greater length of the system (200 cm compared with 150 cm for the Injectomat-C and Perfusor fm) and the speci®c pressure transducer membrane could cause an enlarged ®lling volume, despite the favourably low relative piston compliance. 8 Because we wished to simulate clinical conditions, we did not change the infusion systems and we compared the Ivac 770 system as it is used clinically.
Variation in drug delivery at different¯ow rates was simulated in previous studies using a computerized gravimetric technique. 9 We wanted to go further and demonstrate the individual¯ow rates using a ®xed pressure of 8 mm Hg working against the infusion, comparable to the central venous pressure in a clinical setting. With this technique we could show the time of retrograde¯ow, the time with nō ow and the time taken to return to the original infusion volume (i.e. the volume before the syringe pump's position was changed). A clinical study was not appropriate for ethical reasons, because a direct relationship between haemodynamic response and drug administration is known. 3 In conclusion, the height of a syringe pump, used to give vasoactive agents, relative to the patient should not be changed for transport. If a change in the syringe pump's position is inevitable, the concentration of the drugs administered should be adjusted so that¯ow rates of at least 5 ml h ±1 are required. Infusion systems with a small ®lling volume and small compliance are advantageous. 
